Shares of drugmakers AstraZeneca dropped 2.4% and GSK dipped 3.2%, tracking losses in U.S. and European vaccine makers after ...
GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...
The awards are presented annually to organizations in the Greater Philadelphia and Triangle (North Carolina) regions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback